García-Closas, Montserrat <br/><br/>
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.  [electronic resource] 

 -  Lancet (London, England)   
 - 649-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(05)67137-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arylamine N-Acetyltransferase--genetics<br/>Carcinoma, Transitional Cell--genetics<br/>Case-Control Studies<br/>Female<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Glutathione Transferase--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Polymorphism, Genetic<br/>Polymorphism, Single Nucleotide<br/>Risk Factors<br/>Smoking--adverse effects<br/>Urinary Bladder Neoplasms--genetics